Clinical Trial Update: Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients

View source ↗

Summary

A completed clinical trial comparing Ga-68-NODAGA-MJ9 PET/CT with F-18-FCH PET/CT for imaging in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• F-18-FCH (fluorocholine)
• Ga-68-NODAGA-MJ9

Snippet

Sponsor: University of Lausanne Hospitals | Conditions: Prostate Cancer | Status: COMPLETED